WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 3'2801 Infant (under 12 months) mortality rate: 182
GDP / capita (US$): 11'3121 Child (under 5 years) mortality rate: 212

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 83'387  82'056  80'722  79'392  78'076  66'137  56'337  44'932 
Births 1'902  1'901  1'898  1'892  1'881  1'640  1'742  1'697 
Surviving infants 1'868  1'866  1'862  1'854  1'842  1'588  1'626  1'493 
Pop. less than 5 years 9'273  9'268  9'237  9'131  8'923  7'808  8'266  6'894 
Pop. less than 15 years 25'838  25'555  25'275  24'964  24'605  23'430  22'265  18'105 
Female 15-49 years 21'347  21'023  20'693  20'373  20'071  16'032  12'872  10'219 

Number of reported case

(Click for retrospective incidence data for Egypt)
Diphtheria 59  333 
Japanese encephalitis
Measles 1'314  405  245  26  16  2'633  887  839 
Mumps 7'626  20'390  531  26  1'390 
Pertussis 49 
Polio* 565  2'006 
Rubella 21  34  35  30  461  24 
Rubella (CRS)
Tetanus (neonatal) 20  20  321  3'275  2'965 
Tetanus (total)** 264  597  4'952  6'644 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Egypt)
Vaccine year result method % card seen                                                
BCG 2013  99  DHS   59  96  98  95  98  98  98  89  72 
DTP1 2013  99  DHS   59  96  97  94  97  97  98 
DTP3 2013  97  DHS   59  94  97  93  97  97  98  87  84 
DTP4          93 
IPV1         
HepB_BD         
HepB3 2013  97  DHS   59  94  97  93  97  97  98 
Hib3          94 
JapEnc         
MCV1          93  96  93  96  96  98  87  78 
MCV2          93  96  92  97  97  97 
PCV1         
PCV3         
Pol3 2013  97  DHS   59  94  97  93  97  97  98  87  84 
Rota1         
Rota_last         
Rubella1          93  96  96 
TT2plus 2013  29  DHS   59  71  61 
PAB         
VAD1          98 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Egypt)
BCG 96  98  95  98  98  98  89  50 
DTP1 96  97  94  97  97  98  95  80 
DTP3 94  97  93  96  97  98  87  57 
HepB3 94  97  93  96  97  98 
HepB_BD
Hib3 94 
MCV1 93  96  93  96  96  98  86  41 
MCV2 93  96  92  97  97  97 
PAB 86  86  86  86  86  80  74 
PCV3
Pol3 94  97  93  96  97  98  87  67 
Rota_last

Number of districts in the country 279  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 90
From 80 to 89% 4
From 50 to 79% 6
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 1 week; Yes
DT 2, 4, 6, 18 months; Yes risk groups
DTwP 18 months; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HepB_Adult 1st contact; +1 month, +6 months; Health workers and patients with renal dialysis
HepB_Pediatric 2, 4, 6 months; Yes
IPV 2, 4, 6, months; Yes From December 2015
Influenza Yes Health care workers, Haj or other travellers
MMR 12, 18 months; Yes
MenAC 4, 6, 12, 15 years; Yes
OPV 2, 4, 6, 9,12, 18 months; Yes
TT 1st contact; +2, +6 months; +1, +1 year; Yes pregnant women
Td 7, 9 years; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2015-2016  2010-2014    2010-2014  2007-2011    10 years 
Nº of districts with microplans that include activities to raise immunization coverage number 279  279  27  273  273  29  265 

System performance

Total Nº districts in country number 279  279  275  273  273  271  265 
Nº districts with DTP3 coverage >=80% number 262  262  259  264  267  271 
% of districts with DTP3 coverage >=80% From 0 to 100% 94  94  94  97  98  100 
Nº districts with measles (MCV1) coverage >=95% number 222  218  242  241  244  233   
% of districts with MCV1 coverage >=95% From 0 to 100% 80  78  88  88  89  86   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%       100    100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.